Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban
Andreas Koster, Marian Kukucka, Friedhelm Bach, Oliver Meyer, Thomas Fischer, Fritz Mertzlufft, Matthias Loebe, Roland Hetzer, Hermann Kuppe
Dive into the research topics of 'Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban'. Together they form a unique fingerprint.